{"title":"菲尔德回应HHS肯尼迪关于MH药物，报销的言论","authors":"Valerie A. Canady","doi":"10.1002/mhw.34345","DOIUrl":null,"url":null,"abstract":"<p>Recently installed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr.'s plans and policy proposals involving critical mental health-related issues as the “validity” of antidepressants and antipsychotic medication, Medicare reimbursement changes and the reference to autism as a “disease,” has raised concerns in the field with some asserting a need to be at the table and ensure their voices are heard.</p>","PeriodicalId":100916,"journal":{"name":"Mental Health Weekly","volume":"35 8","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Field responds to HHS Kennedy's remarks about MH medications, reimbursement\",\"authors\":\"Valerie A. Canady\",\"doi\":\"10.1002/mhw.34345\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Recently installed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr.'s plans and policy proposals involving critical mental health-related issues as the “validity” of antidepressants and antipsychotic medication, Medicare reimbursement changes and the reference to autism as a “disease,” has raised concerns in the field with some asserting a need to be at the table and ensure their voices are heard.</p>\",\"PeriodicalId\":100916,\"journal\":{\"name\":\"Mental Health Weekly\",\"volume\":\"35 8\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mental Health Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/mhw.34345\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mental Health Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mhw.34345","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
最近上任的卫生与公众服务部（HHS）部长小罗伯特·f·肯尼迪（Robert F. Kennedy, Jr.）的计划和政策建议涉及到一些关键的精神健康问题，如抗抑郁药和抗精神病药物的“有效性”，医疗保险报销的变化，以及将自闭症作为一种“疾病”的说法，这些都引起了该领域的关注，一些人声称有必要坐在谈判桌上，确保他们的声音被听到。
Field responds to HHS Kennedy's remarks about MH medications, reimbursement
Recently installed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr.'s plans and policy proposals involving critical mental health-related issues as the “validity” of antidepressants and antipsychotic medication, Medicare reimbursement changes and the reference to autism as a “disease,” has raised concerns in the field with some asserting a need to be at the table and ensure their voices are heard.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
